LGUG.L vs. BIGT.L

Last updated Jul 16, 2026

LGUG.L (L&G US Equity UCITS ETF) and BIGT.L (L&G Pharma Breakthrough UCITS ETF) are both exchange-traded funds - LGUG.L is a Large Cap Blend Equities fund tracking the Russell 1000 TR USD, while BIGT.L is a Health & Biotech Equities fund tracking the NASDAQ Biotechnology TR USD. Both are passively managed. Over the past 5 years, LGUG.L returned 13.30%/yr vs 3.20%/yr for BIGT.L. A 0.57 correlation means they provide meaningful diversification when combined. LGUG.L charges 0.05%/yr vs 0.49%/yr for BIGT.L.

Performance

LGUG.L vs. BIGT.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in L&G US Equity UCITS ETF (LGUG.L) and L&G Pharma Breakthrough UCITS ETF (BIGT.L). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LGUG.L achieves a 10.09% return, which is significantly higher than BIGT.L's 7.76% return.

LGUG.L

• 1D: -0.36%
• 1M: -0.25%
• 6M: 10.15%
• YTD: 10.09%
• 1Y: 20.82%
• 3Y*: 19.28%
• 5Y*: 13.30%
• 10Y*: —

BIGT.L

• 1D: -1.28%
• 1M: 7.11%
• 6M: 6.84%
• YTD: 7.76%
• 1Y: 33.20%
• 3Y*: 9.77%
• 5Y*: 3.20%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

LGUG.L vs. BIGT.L - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
LGUG.L L&G US Equity UCITS ETF	10.09%	9.75%	27.44%	21.53%	-10.98%	29.52%	17.11%	26.81%	-29.04%
BIGT.L L&G Pharma Breakthrough UCITS ETF	7.76%	27.03%	-3.16%	-14.88%	2.68%	-2.30%	23.89%	9.47%	-8.23%

Correlation

The correlation between LGUG.L and BIGT.L is 0.35, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.35
Correlation (3Y) Calculated over the trailing 3-year period	0.38
Correlation (5Y) Calculated over the trailing 5-year period	0.48
Correlation (All Time) Calculated using the full available price history since Nov 9, 2018	0.57

Over the past year, the correlation between LGUG.L and BIGT.L has dropped to 0.35 - well below their long-term average of 0.57, suggesting their price drivers have been diverging.

LGUG.L vs. BIGT.L - Sectors Allocation Comparison

Sectors	LGUG.L	BIGT.L
Technology	37.6%	-
Financial Services	11.9%	-
Communication Services	10.6%	-
Consumer Cyclical	9.7%	-
Healthcare	9.3%	98.1%
Industrials	8.1%	-
Consumer Defensive	4.6%	-
Energy	3.0%	-
Utilities	2.0%	-
Basic Materials	1.6%	1.9%
Real Estate	1.6%	-

Return for Risk

LGUG.L vs. BIGT.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LGUG.L

LGUG.L Risk / Return Rank: 67
LGUG.L Sharpe Ratio Rank: 71
LGUG.L Sortino Ratio Rank: 69
LGUG.L Omega Ratio Rank: 70
LGUG.L Calmar Ratio Rank: 64
LGUG.L Martin Ratio Rank: 60

BIGT.L

BIGT.L Risk / Return Rank: 67
BIGT.L Sharpe Ratio Rank: 66
BIGT.L Sortino Ratio Rank: 65
BIGT.L Omega Ratio Rank: 59
BIGT.L Calmar Ratio Rank: 79
BIGT.L Martin Ratio Rank: 65

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LGUG.L vs. BIGT.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for L&G US Equity UCITS ETF (LGUG.L) and L&G Pharma Breakthrough UCITS ETF (BIGT.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	LGUG.L	BIGT.L	Difference
Sharpe ratio: Return per unit of total volatility	1.83	1.74	+0.10
Sortino ratio: Return per unit of downside risk	2.54	2.43	+0.10
Omega ratio: Gain probability vs. loss probability	1.33	1.29	+0.04
Calmar ratio: Return relative to maximum drawdown	2.59	3.33	-0.74
Martin ratio: Return relative to average drawdown	8.60	9.47	-0.87

LGUG.L vs. BIGT.L - Sharpe Ratio Comparison

The current LGUG.L Sharpe Ratio is 1.83, which is comparable to the BIGT.L Sharpe Ratio of 1.74. The chart below compares the historical Sharpe Ratios of LGUG.L and BIGT.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

LGUG.L vs. BIGT.L - Drawdown Comparison

The maximum LGUG.L drawdown since its inception was -30.90%, smaller than the maximum BIGT.L drawdown of -36.84%. Use the drawdown chart below to compare losses from any high point for LGUG.L and BIGT.L.

Drawdown Indicators

	LGUG.L	BIGT.L	Difference
Max Drawdown Largest peak-to-trough decline	-30.90%	-36.84%	+5.94%
Max Drawdown (1Y) Largest decline over 1 year	-8.01%	-9.93%	+1.92%
Max Drawdown (3Y) Largest decline over 3 years	-21.49%	-28.44%	+6.95%
Max Drawdown (5Y) Largest decline over 5 years	-21.49%	-30.23%	+8.74%
Current Drawdown Current decline from peak	-0.95%	-6.64%	+5.69%
Average Drawdown Average peak-to-trough decline	-7.07%	-17.21%	+10.14%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.42%	3.50%	-1.08%

Volatility

LGUG.L vs. BIGT.L - Volatility Comparison

The current volatility for L&G US Equity UCITS ETF (LGUG.L) is 2.97%, while L&G Pharma Breakthrough UCITS ETF (BIGT.L) has a volatility of 6.49%. This indicates that LGUG.L experiences smaller price fluctuations and is considered to be less risky than BIGT.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LGUG.L	BIGT.L	Difference
Volatility (1M) Calculated over the trailing 1-month period	2.97%	6.49%	-3.52%
Volatility (6M) Calculated over the trailing 6-month period	8.12%	14.29%	-6.17%
Volatility (1Y) Calculated over the trailing 1-year period	11.33%	19.03%	-7.70%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	20.34%	21.46%	-1.12%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	21.39%	23.23%	-1.84%

LGUG.L vs. BIGT.L - Expense Ratio Comparison

LGUG.L has a 0.05% expense ratio, which is lower than BIGT.L's 0.49% expense ratio.

Dividends

LGUG.L vs. BIGT.L - Dividend Comparison

Neither LGUG.L nor BIGT.L has paid dividends to shareholders.

Tickers have no history of dividend payments

Frequently Asked Questions

Can I hold both LGUG.L and BIGT.L in my portfolio?

LGUG.L and BIGT.L have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, LGUG.L or BIGT.L?

On fees, LGUG.L is cheaper at 0.05% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, LGUG.L or BIGT.L?

LGUG.L is cheaper with a 0.05% expense ratio, compared with 0.49% for BIGT.L.

What is the main difference between LGUG.L and BIGT.L?

LGUG.L is categorized as Large Cap Blend Equities, while BIGT.L is Health & Biotech Equities. LGUG.L tracks Russell 1000 TR USD, while BIGT.L tracks NASDAQ Biotechnology TR USD. Their fees differ too: 0.05% for LGUG.L and 0.49% for BIGT.L.